Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:MBRX’

Copyright: nexusplexus / 123RF Stock Photo

13G Filing: Sabby Capital and Moleculin Biotech Inc (MBRX)

Moleculin Biotech Inc (NASDAQ:MBRX): Hal Mintz’s Sabby Capital filed an amended 13D. You can check out Sabby Capital’s latest holdings and......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Moleculin Biotech Inc (MBRX): Proceed With Caution

Moleculin Biotech Inc (NASDAQ:MBRX), an oncology-focused pharmaceutical firm that just joined public markets in June, is making some waves in the biotech......(read more)